Live feed16:46:00·1327dSECFilingvia QuantisnowInterpace Biosciences, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.IDXG· Interpace Biosciences, Inc.Health CareOriginal source
